The safety profile of a medical device is the comprehensive, data-supported description of all known and foreseeable risks, adverse effects, and limitations of use of a product within the scope of its intended purpose. It is not a legally defined term in Regulation (EU) 2017\/745, but rather an aggregation maintained in the technical documentation and clinical evaluation: Annex I Section 8 requires that all known and foreseeable risks and undesirable side effects be minimized and acceptable, while Annex XIV Part A requires the evaluation of safety and performance based on clinical data. The safety profile is therefore product-specific, not substance-specific, and must be updated throughout the entire lifecycle. <\/p>\n
In terms of content, a safety profile comprises several levels: the accepted residual risks from risk management including disclosed warnings and contraindications, the adverse events observed in clinical investigations and in practice with frequency estimates, the product-specific malfunctions and material events, and the application-related risks including foreseeable misuse. Data sources include the risk management file, the biological evaluation report, verification and validation data, the clinical evaluation, post-market surveillance, post-market clinical follow-up, vigilance reports and trend reports, feedback from service and complaints, as well as literature and databases on similar products. It is characteristic that these sources have varying reliability and completeness, and their integration requires methodological weighting, particularly with regard to underreporting in spontaneous reporting systems and missing denominator data. <\/p>\n
The safety profile is the substantive core of several recurring documents. In the periodic safety update reports for Class IIa, IIb, and III devices pursuant to Article 86 of Regulation (EU) 2017\/745, it is updated together with sales figures, user population, and benefit-risk conclusions; for Class I devices, this is done in the post-market surveillance report pursuant to Article 85. For Class III devices and implantable devices, it is incorporated into the summary of safety and clinical performance pursuant to Article 32, which must also be understandable to patients. If the update reveals a shift\u2014such as new event types, higher frequencies, or a previously undescribed interaction\u2014risk management, clinical evaluation, instructions for use, and, where applicable, design must be adapted, and reporting obligations and field safety corrective actions must be reviewed. <\/p>\n
In pharmaceutical law, the safety profile is maintained on a substance-specific basis and updated through pharmacovigilance structures such as risk management plans, periodically updated safety reports, and signal detection with defined causality assessments; the focus is on adverse reactions in the sense of undesirable medicinal product effects. In the case of medical devices, by contrast, malfunctions, performance degradations, material events, and application errors predominate, and the reporting logic is linked to the incident, not to an adverse drug reaction. The safety profile differs from the benefit-risk ratio in that it describes the risk side, whereas the benefit-risk assessment compares this description with the clinical benefit and condenses it into an acceptability statement. An unchanged safety profile may nevertheless lead to a different assessment in the event of a changed benefit situation, for example due to new therapeutic alternatives. <\/p>\n
The documented safety profile determines the safety architecture of a clinical investigation. From it, the expected adverse events and product defects are derived, which must be defined as such in the investigation plan, as well as safety endpoints, inclusion and exclusion criteria, stopping rules, informed consent content, and the need for a data monitoring committee. It is also the reference for assessing whether an observed event is expected or unexpected, which is directly relevant for reporting timelines and for communication with authorities and ethics committees. <\/p>\n
Conversely, the clinical investigation is one of the few sources that provides frequencies with a reliable denominator and prospective recording, thereby closing gaps left by spontaneous reports. Its results are incorporated into the update of the risk management file, clinical evaluation, and summary report, and frequently justify changes to instructions for use and warnings. Full-service CROs such as Mediconomics support manufacturers and sponsors in translating the documented safety profile into investigation plans and safety reporting systems, and in preparing study and follow-up data for periodic updates. <\/p>\n
Is the safety profile a separate document in the technical documentation?<\/strong><\/p>\n Typically not as a separate document. It is maintained in the risk management file, clinical evaluation, post-market surveillance report or periodic safety update report, and in the summary of safety and clinical performance, and must be consistent across these documents. <\/p>\n How often must it be updated?<\/strong><\/p>\n Pursuant to Article 86 of Regulation (EU) 2017\/745, at least annually for Class III devices and implantable devices, at least every two years for Class IIa and IIb devices; additionally on an event-driven basis when new findings emerge.<\/p>\n Do application errors count as part of the safety profile?<\/strong><\/p>\n Yes. Foreseeable misuse and ergonomically induced application errors are part of the risk assessment and therefore part of the safety profile; they are also relevant under vigilance law. <\/p>\n The safety profile of a medical device is the comprehensive, data-supported description of all known and foreseeable risks, adverse effects, and limitations of use of a product within the scope of its intended purpose. It is not a legally defined term in Regulation (EU) 2017\/745, but rather an aggregation maintained in the technical documentation and […]<\/p>\n","protected":false},"author":10,"featured_media":0,"parent":0,"template":"","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"glossary-cat":[24],"class_list":["post-7770","glossary","type-glossary","status-publish","hentry","glossary-cat-medizinprodukte-ivd"],"acf":[],"related_terms":"","external_url":"","internal_reference_id":"","_links":{"self":[{"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/glossary\/7770","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/glossary"}],"about":[{"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/types\/glossary"}],"author":[{"embeddable":true,"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/users\/10"}],"version-history":[{"count":0,"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/glossary\/7770\/revisions"}],"wp:attachment":[{"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/media?parent=7770"}],"wp:term":[{"taxonomy":"glossary-cat","embeddable":true,"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/glossary-cat?post=7770"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}Regulatory References<\/h2>\n
\n